期刊文献+

以血管内皮生长因子及血管内皮生长因子受体为靶点的抗肿瘤血管生成的治疗进展 被引量:3

Advance of Targeting VEGF and VEGFR in Anti-angiogenesis of Tumor
暂未订购
导出
摘要 肿瘤生长、浸润和转移都依赖于肿瘤血管生成,而肿瘤血管生成又受多种因子影响.血管内皮生长因子(VEGF)是最重要的血管生成因子,可特异性作用于血管内皮细胞生长因子受体(VEGFR),通过促进内皮细胞增殖,增加血管通透性,而诱导肿瘤血管生成.因而以VEGF及VEGFR为靶点抗肿瘤血管生成已越来越成为人们研究的热点.对以VEGF及VEGFR为靶点抗肿瘤血管生成的治疗进展作一综述. Tumor growth, invasion and metastases all depend on tumor angiogenesis, tumor angiogenesis are influenced by many factors. Vascular endothelial growth factor (VEGF) is a very important factor in the process of angiogenesis. It can bind with vascular endothelial growth factor receptor (VEGFR), and induce tumor angiogenesis by promoting generation of endothelial cell and augmenting vasopermeability. So the study of targeting VEGF and VEGFR has become hot. This article reviewed advance in of tumor of targeting VEGF and VEGFR anti-angiogenesis.
作者 李淼 陈明清
出处 《昆明医学院学报》 2008年第B06期70-73,共4页 Journal of Kunming Medical College
基金 云南省自然科学基金资助项目(2005C0073M) 昆明医学院创新群体研究基金资助项目(KMC2005DG01)
关键词 血管内皮生长因子 血管内皮生长因子受体 抗血管生成 肿瘤 VEGF VEGFR Anti-angiogenesis Tumor
  • 相关文献

参考文献10

  • 1FUJISAWA T, WATANABE J, KAMATA Y, et al. Effect of p53 gene transfection on vascular endothelial growth factor expression in endometrial cancer cells [ J ]. Exp Mol Pathol,2003, 74:276 - 281.
  • 2ZHANG L, YANG N, MOHAMED HADLEY A, et al.Veetor based RNAi,a novel tool for isoform specific knock down of VEGF and antiangiogenesis gene therapy of cancer[ J ]. Biochem Biophys Res Commun, 2003,303:1169 - 1178.
  • 3WENG D E, WEISS P, KELLACKEY C, et al. Angiozyme pharrnacokinetic and safety results : a phase Ⅰ/ Ⅱ study in patients with refractory solid tumours [ M ]. USA:Proc Am Soc Clin Oncol,2001:99.
  • 4MANLEY PW, FURET P, BOLD G, et al. Anthranilic acidamides:a novel class of antiangiogenic VEGF receptor kinase inhibitors [J]. J Med Chem,2002,45 ( 26):5687 - 5693.
  • 5KABBINVAR F F,SCHULZ J,MCCLEOD M,et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first line metastatic colorectal cancer :results of a randomized phase Ⅱ trial [J]. J Clin Oncol,2005,23(16): 3697 - 3705.
  • 6LIN P, SANKAR S, SHAN S.Inhibition of tumor growth by targeting tumor endothehum using a soluble vascular endothelial growth factor receptor [J]. Cell Growth Differ, 1998,9 ( 1 ):49 - 58.
  • 7NIEDERMAN T M,GHOGAWALA Z,CARTER B S,et al. Antitumour activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptor [J ]. Proc Natl Acad Sci USA ,2002,99( 10):7009 - 7014.
  • 8OLSON T A. Targeting the tumor vasculature;inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate[ J ]. Cancer, 1997,73(6 ), 865 - 870.
  • 9QI J H,EBRAHEM Q,NINA M,et al. A novel function for tissue inhibitor of metalloproteinases - 3 ( TIMP3):inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor - 2 [J ]. Nature Meal,2003,9 (4):407 - 415.
  • 10BIKFALVI A. Recent developments in the inhibition of angiogenesis: examples from studies on plate let factor - 4 and the VEGF/VEGFR system [J ]. Biochem Pharmaeol, 2004,68:1017 - 1021.

同被引文献30

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部